Literature DB >> 7285474

Systemic treatment of osteogenesis imperfecta.

J A Albright.   

Abstract

Seventy percent of published articles on the medical treatment of osteogenesis imperfecta have claimed beneficial results for 20 different agents. This observation conflicts with current practice since no form of treatment has been accepted as effective in dealing with the disease. A few medications or combinations of medications hold some promise, but adequate documentation must be availble before they can be accurately assessed. It is essential that the practitioner maintain a high degree of skepticism toward positive results of treatment regardless of the source. At the present time, no agent is available which will be of any value to the practitioner who has a patient with osteogenesis imperfecta.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285474

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

Review 1.  Osteogenesis imperfecta: practical treatment guidelines.

Authors:  F Antoniazzi; M Mottes; P Fraschini; P C Brunelli; L Tatò
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

2.  Vertebral bone mineral content in osteogenesis imperfecta.

Authors:  D Kurtz; K Morrish; J Shapiro
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

3.  Current and emerging treatments for the management of osteogenesis imperfecta.

Authors:  Elena Monti; Monica Mottes; Paolo Fraschini; Piercarlo Brunelli; Antonella Forlino; Giacomo Venturi; Francesco Doro; Silvia Perlini; Paolo Cavarzere; Franco Antoniazzi
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

4.  Osteogenesis imperfecta: a case report and review of literature.

Authors:  Bo Edelu; Ik Ndu; In Asinobi; Ha Obu; Gn Adimora
Journal:  Ann Med Health Sci Res       Date:  2014-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.